2020. Efficacy and Safety of Long-Term Tildrakizumab for Plaque Psoriasis: 4-Year Results from Resurface 1 and Resurface 2. SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s39. DOI:https://doi.org/10.25251/skin.4.supp.39.